Allison Rosen, Director: Project ECHO at American Cancer Society, shared a post on X:
“Alberto Bardelli discusses the exposome influences that contribute to early-onset disease. Innovative research in proteomics and molecular profiling will provide new insights into potential preventive, diagnostic and therapeutic strategies.”
